日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Mosaic vaccine design targeting mutational spike protein of SAR-SCoV-2: An immunoinformatics approach

针对SARS-CoV-2突变刺突蛋白的嵌合疫苗设计：一种免疫信息学方法

期刊:Bioimpacts
影响因子:2.2
doi:10.34172/bi.2023.26443
Ysrafil, Ysrafil; Imran, Arlan K; Wicita, Prisca Syafriani; Kamba, Vyani; Mohamad, Fihrina; Ismail, Ismail; Nurung, Ayyub Harly; Gama, Noviyanty Indjar; Pratiwi, Sari Eka; Astuti, Indwiani; Nainu, Firzan; Emran, Talha Bin
SARS-CoV-2
免疫/内分泌
发表日期：2025
文献求助 收藏

Methylcobalamin as a candidate for chronic peripheral neuropathic pain therapy: review of molecular pharmacology actiona

甲基钴胺素作为慢性周围神经性疼痛治疗的候选药物：分子药理学作用机制综述

期刊:Korean Journal of Pain
影响因子:3.1
doi:10.3344/kjp.24171
Ramadhani, Amilia; Astuti, Indwiani; Widiastuti, Maria Goreti; Purwanti, Nunuk
发表日期：2024
文献求助 收藏

miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia

miRNA-21作为印度尼西亚前列腺癌患者的高潜力前列腺癌生物标志物

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2023.24.3.1095
Gunawan, Regina R; Astuti, Indwiani; Danarto, H Raden
前列腺癌
miRNA
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

Circulation microRNA expression profiles in patients with complete responses to chemoradiotherapy in nasopharyngeal carcinoma

鼻咽癌患者接受放化疗后完全缓解时循环microRNA表达谱分析

期刊:Non-coding RNA Research
影响因子:4.7
doi:10.1016/j.ncrna.2022.09.005
Wardana, Tirta; Chasanah, Siti Nur; Oktriani, Risky; Herawati, Cita; Anwar, Sumadi Lukman; Astuti, Indwiani; Mubarika Haryana, Sofia
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients

潜在的血浆生物标志物：miRNA-29c、miRNA-21 和 miRNA-155 在肝细胞癌患者临床进展中的作用

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0263298
Ratnasari, Neneng; Lestari, Puji; Renovaldi, Dede; Raditya Ningsih, Juwita; Qoriansas, Nanda; Wardana, Tirta; Hakim, Suharno; Signa Aini Gumilas, Nur; Indrarti, Fahmi; Triwikatmani, Catharina; Bayupurnama, Putut; Setyo Heriyanto, Didik; Astuti, Indwiani; Mubarika Harjana, Sofia
miRNA
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach

利用免疫信息学方法设计针对SARS-CoV-2的多表位肽疫苗候选物

期刊:Bioimpacts
影响因子:2.2
doi:10.34172/bi.2022.23769
Ysrafil, Ysrafil; Sapiun, Zulfiayu; Astuti, Indwiani; Anasiru, Mohammad Anas; Slamet, Nangsih Sulastri; Hartati, Hartati; Husain, Fadli; Damiti, Sukmawati Ahmad
SARS-CoV-2
免疫/内分泌
发表日期：2022
文献求助 收藏

Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression

壳聚糖纳米颗粒介导的抗miRNA-324-5p通过调控GLI1表达降低卵巢癌细胞增殖的作用

期刊:Bioimpacts
影响因子:2.2
doi:10.34172/bi.2021.22119
Ysrafil, Ysrafil; Astuti, Indwiani
肿瘤
肿瘤免疫
GLI1
信号转导
卵巢癌
miRNA
细胞生物学
发表日期：2022
文献求助 收藏

The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia

hsa-mir-106b-5p作为印度尼西亚前列腺癌患者液体生物标志物的潜力

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2021.22.3.837
Bonnu, Christin H; Ramadhani, Anggia N; Saputro, Ranu B; Sesotyosari, Salsabila L; Danarto, R; Astuti, Indwiani; Haryana, Sofia M
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review

miRNA疗法在严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 感染中的应用潜力：综述

期刊:
影响因子:
doi:10.1016/j.jpha.2021.03.003
Rizkita, Leonny Dwi; Astuti, Indwiani
炎症/感染
miRNA
SARS-CoV-2
微生物学
发表日期：2021
文献求助 收藏

Chemotherapy Negates the Effect of SDF1 mRNA to Distant Metastasis and Poor Overall Survival in Breast Cancer Patients

化疗可抵消 SDF1 mRNA 对乳腺癌患者远处转移和总体生存率低的影响

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2021.22.3.757
Kristanto Yuli Yarso, Monica Bellynda, Akhmad Azmiardi, Brian Wasita, Didik Setyo Heriyanto, Indwiani Astuti, Mohammad Hakimi, Teguh Aryandono
肿瘤
乳腺癌
发表日期：2021
文献求助 收藏